Appl Clin Inform
DOI: 10.1055/a-2595-4849
Case Report

Special Issue on CDS Failures: A Rash Decision: Implementing an EHR-Integrated Penicillin Allergy Delabeling Protocol Without Adequate Clinician Support

Alexander S. Plattner
1   Pediatrics, Division of Infectious Diseases, Washington University in St Louis School of Medicine, St Louis, United States (Ringgold ID: RIN12275)
2   Institute for Informatics, Data Science, and Biostatistics, Washington University in St Louis School of Medicine, St Louis, United States (Ringgold ID: RIN12275)
,
Christine R Lockowitz
3   Pharmacy, St Louis Children's Hospital, St Louis, United States (Ringgold ID: RIN21796)
,
Rebecca G Same
4   Pediatrics, Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, United States (Ringgold ID: RIN6567)
5   University of Pennsylvania Perelman School of Medicine, Philadelphia, United States (Ringgold ID: RIN14640)
,
Monica Abdelnour
1   Pediatrics, Division of Infectious Diseases, Washington University in St Louis School of Medicine, St Louis, United States (Ringgold ID: RIN12275)
,
Samuel Chin
6   Pediatrics, Washington University in St Louis School of Medicine, St Louis, United States (Ringgold ID: RIN12275)
,
Matthew J Cormier
6   Pediatrics, Washington University in St Louis School of Medicine, St Louis, United States (Ringgold ID: RIN12275)
,
Megan S Daugherty
6   Pediatrics, Washington University in St Louis School of Medicine, St Louis, United States (Ringgold ID: RIN12275)
,
Alexandra E Grier
6   Pediatrics, Washington University in St Louis School of Medicine, St Louis, United States (Ringgold ID: RIN12275)
,
Nicholas B Hampton
7   Business Intelligence Data Solutions, BJC HealthCare, Saint Louis, United States (Ringgold ID: RIN7552)
,
Mackenzie R. Hoffard
2   Institute for Informatics, Data Science, and Biostatistics, Washington University in St Louis School of Medicine, St Louis, United States (Ringgold ID: RIN12275)
8   General Medicine and Geriatrics, Washington University in St Louis School of Medicine, St Louis, United States (Ringgold ID: RIN12275)
,
Sarah S Mehta
9   Pediatrics, Division of Allergy and Pulmonary Medicine, Washington University in St Louis School of Medicine, St Louis, United States (Ringgold ID: RIN12275)
10   Pediatrics, Division of Rheumatology/Immunology, Washington University in St Louis School of Medicine, St Louis, United States (Ringgold ID: RIN12275)
,
Jason G Newland
11   Pediatrics, Division of Infectious Diseases, Nationwide Children's Hospital, Columbus, United States (Ringgold ID: RIN2650)
,
Kevin S O'Bryan
6   Pediatrics, Washington University in St Louis School of Medicine, St Louis, United States (Ringgold ID: RIN12275)
,
Matthew M Sattler
1   Pediatrics, Division of Infectious Diseases, Washington University in St Louis School of Medicine, St Louis, United States (Ringgold ID: RIN12275)
,
Mehr Z Shah
9   Pediatrics, Division of Allergy and Pulmonary Medicine, Washington University in St Louis School of Medicine, St Louis, United States (Ringgold ID: RIN12275)
,
G Lucas Starnes
1   Pediatrics, Division of Infectious Diseases, Washington University in St Louis School of Medicine, St Louis, United States (Ringgold ID: RIN12275)
,
Valerie Yuenger
3   Pharmacy, St Louis Children's Hospital, St Louis, United States (Ringgold ID: RIN21796)
,
Alysa G Ellis
9   Pediatrics, Division of Allergy and Pulmonary Medicine, Washington University in St Louis School of Medicine, St Louis, United States (Ringgold ID: RIN12275)
,
Evan E Facer
1   Pediatrics, Division of Infectious Diseases, Washington University in St Louis School of Medicine, St Louis, United States (Ringgold ID: RIN12275)
› Author Affiliations
Supported by: National Institutes of Health T32 AI106688

Approximately 10% of patients have a documented penicillin “allergy”; however, up to 95% have subsequent negative testing. These patients may receive suboptimal antibiotics, leading to longer hospitalizations and higher costs, rates of resistant and nosocomial infections, and all-cause mortality. To mitigate these risks in children, we implemented an inpatient penicillin allergy delabeling protocol and integrated into the electronic health record (EHR) through a mixed methods approach of clinical decision support (CDS). We describe our protocol implementation across three sequential phases: “Pilot”, “Active Antimicrobial Stewardship Program (ASP)”, and “Mixed CDS”. We highlight several potential pitfalls that may have contributed to poor clinician adoption. Patients were risk-stratified as non-allergic, low-risk, or high-risk based on history. Process measures included: evaluation rate, oral challenge rate for low-risk, and allergy referral rate for high-risk or low-risk when oral challenge was deferred. Primary outcome measure was penicillin allergy delabeling rate among low-risk or non-allergic. Balancing measures included rate of epinephrine or antihistamine administrations. The Pilot and ASP Phases used clinician education and an order set, but were mostly manual processes. The Mixed CDS Phase introduced interruptive alerts, dynamic text in note templates, and patient list columns to guide clinicians, but little education was provided. The Mixed CDS Phase had the lowest evaluation rate compared to the Pilot and Active ASP Phases (6.4% vs 25% vs 15%). However, when evaluation was performed, the Mixed CDS Phase had the highest oral challenge rate (33% vs 26% vs 13%) and delabeling rate (43% vs 33% vs 27%). No adverse events occurred. CDS tools improve clinician decision-making and optimize patient care. However, relying on CDS for complex clinical evaluations can lead to failure when clinicians cannot find the tool or appreciate the importance. Person-to-person communication can be vital in establishing a process and educating intended users for successful CDS implementat



Publication History

Received: 09 December 2024

Accepted after revision: 26 April 2025

Accepted Manuscript online:
28 April 2025

© . Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany